Back to News
Market Impact: 0.25
Dr. Reddy's Laboratories Q2 Earnings Call Highlights
Source: marketbeat.com
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Dr. Reddy’s Laboratories reported second-quarter FY2027 revenue of INR 8,671 crore ($905 million), down 1.5% year over year but up 7.4% sequentially. Lower North American lenalidomide sales offset growth in the underlying business.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment
RDY-0.20
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- AI agents could disrupt bank deposits. Why Wall Street may be overreacting
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row